XYL Strangle Strategy
XYL (Xylem Inc.), in the Industrials sector, (Industrial - Machinery industry), listed on NYSE.
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water Infrastructure; Applied Water; Measurement and Control Solutions; and Water Solutions and Services segments. The company offers water, wastewater, and storm water pumps and controls and systems; filtration, disinfection, and biological treatment equipment under the Flygt, Ionpure, Leopold, Neptune Benson, Sanitare, Wallace & Tiernan, and Wedeco brands; and pumps, valves, heat exchangers, controls, and dispensing equipment used for water and focuses on the residential, commercial and industrial markets under the Rule, Bell & Gossett, Flojet, Goulds Water Technology, Jabsco, and Lowara brands. It also provides smart meters, network communication devices, data analytics, test instruments, controls, sensor devices, software and managed services, critical infrastructure services, cloud-based analytics, and remote monitoring and data management under the Ebro, Sensus, Sentec, Smith Blair, WTW, YSI, and Xylem Vue brands. In addition, the company offers preventative maintenance services, rapid response mobile services, digitally enabled/outsourced solutions, process and wastewater treatment systems, environmental remediation, odor and corrosion control, filtration, reverse osmosis, continuous deionization, and mobile dewatering equipment and rental services; and municipal services comprising odor and corrosion control services, as well as condition assessment and asset management, and pressure monitoring solutions under the Grindex, Mar Cor, and Godwin brands. Xylem Inc. was formerly known as ITT WCO, Inc. and changed its name to Xylem Inc. in July 2011.
XYL (Xylem Inc.) trades in the Industrials sector, specifically Industrial - Machinery, with a market capitalization of approximately $27.68B, a trailing P/E of 29.05, a beta of 1.04 versus the broader market, a 52-week range of 105.29-154.27, average daily share volume of 2.2M, a public-listing history dating back to 2011, approximately 22K full-time employees. These structural characteristics shape how XYL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.04 places XYL roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. XYL pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on XYL?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current XYL snapshot
As of June 30, 2026, spot at $118.48, ATM IV 26.10%, IV rank 39.18%, expected move 7.48%. The strangle on XYL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this strangle structure on XYL specifically: XYL IV at 26.10% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 7.48% (roughly $8.87 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated XYL expiries trade a higher absolute premium for lower per-day decay. Position sizing on XYL should anchor to the underlying notional of $118.48 per share and to the trader's directional view on XYL stock.
XYL strangle setup
The XYL strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With XYL near $118.48, the first option leg uses a $125.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed XYL chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 XYL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $125.00 | $0.80 |
| Buy 1 | Put | $115.00 | $1.28 |
XYL strangle risk and reward
- Net Premium / Debit
- -$207.50
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$207.50
- Breakeven(s)
- $112.93, $127.08
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
XYL strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on XYL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$11,291.50 |
| $26.21 | -77.9% | +$8,671.95 |
| $52.40 | -55.8% | +$6,052.40 |
| $78.60 | -33.7% | +$3,432.86 |
| $104.79 | -11.6% | +$813.31 |
| $130.99 | +10.6% | +$391.24 |
| $157.18 | +32.7% | +$3,010.79 |
| $183.38 | +54.8% | +$5,630.33 |
| $209.57 | +76.9% | +$8,249.88 |
| $235.77 | +99.0% | +$10,869.43 |
When traders use strangle on XYL
Strangles on XYL are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the XYL chain.
XYL thesis for this strangle
The market-implied 1-standard-deviation range for XYL extends from approximately $109.61 on the downside to $127.35 on the upside. A XYL long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current XYL IV rank near 39.18% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on XYL should anchor more to the directional view and the expected-move geometry. As a Industrials name, XYL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to XYL-specific events.
XYL strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. XYL positions also carry Industrials sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move XYL alongside the broader basket even when XYL-specific fundamentals are unchanged. Always rebuild the position from current XYL chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on XYL?
- A strangle on XYL is the strangle strategy applied to XYL (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With XYL stock trading near $118.48, the strikes shown on this page are snapped to the nearest listed XYL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are XYL strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the XYL strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 26.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$207.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a XYL strangle?
- The breakeven for the XYL strangle priced on this page is roughly $112.93 and $127.08 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current XYL market-implied 1-standard-deviation expected move is approximately 7.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on XYL?
- Strangles on XYL are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the XYL chain.
- How does current XYL implied volatility affect this strangle?
- XYL ATM IV is at 26.10% with IV rank near 39.18%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.